Regulacje i polityka gospodarcza · 19/11/2014

National Institutes of Health to Grant Exclusive Patent License for Infectious Prion Protein Detection to Amprion, Inc.

The National Institutes of Health is seeking to grant an exclusive patent license to Amprion, Inc. to practice inventions related to detecting infectious prion protein through seeded conversion of recombinant prion protein, with potential worldwide applicability.